The gene encoding the approved CAR target ERBB2 was expressed more highly in matched normal tissue than in tumor tissue, indicating that the new targets uncovered herewith may possess greater tumor-vs-nontumor stratification abilities than at least one of two established HNSC CAR targets. This evidence concerns the gene ERBB2 and neoplasm.